GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Opsens Inc (TSX:OPS) » Definitions » Net Issuance of Preferred Stock

Opsens (TSX:OPS) Net Issuance of Preferred Stock : C$0.00 Mil (TTM As of Aug. 2023)


View and export this data going back to 2006. Start your Free Trial

What is Opsens Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Opsens's net issuance of preferred for the three months ended in Aug. 2023 was C$0.00 Mil. The number is 0, which means that Opsens has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Opsens's net issuance of preferred for the trailing twelve months (TTM) ended in Aug. 2023 was C$0.00 Mil.


Opsens Net Issuance of Preferred Stock Historical Data

The historical data trend for Opsens's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Opsens Net Issuance of Preferred Stock Chart

Opsens Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
Net Issuance of Preferred Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Opsens Quarterly Data
Nov18 Feb19 May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23
Net Issuance of Preferred Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Opsens Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Aug. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Opsens Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Opsens's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.


Opsens (TSX:OPS) Business Description

Traded in Other Exchanges
N/A
Address
750, Boulevard du Parc-Technologique, Quebec, QC, CAN, G1P 4S3
OpSens Inc. is engaged in physiological measurements such as Fractional Flow Reserve (FFR) and Diastolic Pressure Ratio (dPR) in the coronary artery disease market and in transcatheter aortic valve replacement (TAVR) in the structural heart market. It operates in two segments that are Medical and Industrial. In Medical segment it supplies an optical-based pressure guidewire (OptoWire), a guidewire used in the TAVR procedure (SavvyWire) and a wide range of miniature optical sensors to measure pressure and temperature to be used in a wide range of applications that can be integrated into other medical devices. Industrial segment includes developing, manufacturing and installing fibre optic sensing solutions for industrial applications. Majority of its revenue is derived from Medical segment.
Executives
Alan Milinazzo Director
Robin Villeneuve Senior Officer
Fiera Capital Corporation (formerly Fiera Sceptre Inc.) 10% Security Holder

Opsens (TSX:OPS) Headlines

No Headlines